Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT01776086
Other study ID # E-12-471
Secondary ID
Status Withdrawn
Phase N/A
First received January 23, 2013
Last updated July 9, 2013
Start date January 2013
Est. completion date December 2013

Study information

Verified date July 2013
Source Englewood Hospital and Medical Center
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this studying is to develop and characterize neuropsychological testing software for evaluating the prefrontal and temporal function of patients. As no software has been used for this purpose, this study will gather pilot data on the baseline performance of patients in a hospital setting that lack any neurological impairment. After creating this baseline, later experiments can be proposed to compare the performance in normal subjects with those who have neurologic injury or disease.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date December 2013
Est. primary completion date July 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Inpatients > = 18 years of age

- Patient must be able to provide informed consent

Exclusion Criteria:

- Patients with score of < 26 on Folstein Mini-Mental Status Exam

- Patients with known brain lesions

- Patients with history of stroke, neurologic disease or dementia

- Patients with acute illness or who are in imminent distress

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms

  • Inpatients With Normal Neurological Function

Intervention

Behavioral:
Neurological testing


Locations

Country Name City State
United States Englewood Hospital and Medical Center Englewood New Jersey

Sponsors (1)

Lead Sponsor Collaborator
Englewood Hospital and Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Determination of "normal performance" curve The purpose of this study is to generate a curve of "normal performance" on the neurological test for hospitalized patients of different ages 1 year No